Immunocompromised Patients with Acute Respiratory Distress Syndrome: Secondary Analysis of the LUNG SAFE Database

Overview

Journal Crit Care

Specialty Critical Care

Date 2018 Jun 14

PMID 29895331

Citations 42

Authors

Andrea Cortegiani

Fabiana Madotto

Cesare Gregoretti

Giacomo Bellani

John G Laffey

Tai Pham

Frank van Haren

Antonino Giarratano

Massimo Antonelli

Antonio Pesenti

Giacomo Grasselli

Affiliations

Soon will be listed here.

Abstract

Background: The aim of this study was to describe data on epidemiology, ventilatory management, and outcome of acute respiratory distress syndrome (ARDS) in immunocompromised patients.

Methods: We performed a post hoc analysis on the cohort of immunocompromised patients enrolled in the Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) study. The LUNG SAFE study was an international, prospective study including hypoxemic patients in 459 ICUs from 50 countries across 5 continents.

Results: Of 2813 patients with ARDS, 584 (20.8%) were immunocompromised, 38.9% of whom had an unspecified cause. Pneumonia, nonpulmonary sepsis, and noncardiogenic shock were their most common risk factors for ARDS. Hospital mortality was higher in immunocompromised than in immunocompetent patients (52.4% vs 36.2%; p < 0.0001), despite similar severity of ARDS. Decisions regarding limiting life-sustaining measures were significantly more frequent in immunocompromised patients (27.1% vs 18.6%; p < 0.0001). Use of noninvasive ventilation (NIV) as first-line treatment was higher in immunocompromised patients (20.9% vs 15.9%; p = 0.0048), and immunodeficiency remained independently associated with the use of NIV after adjustment for confounders. Forty-eight percent of the patients treated with NIV were intubated, and their mortality was not different from that of the patients invasively ventilated ab initio.

Conclusions: Immunosuppression is frequent in patients with ARDS, and infections are the main risk factors for ARDS in these immunocompromised patients. Their management differs from that of immunocompetent patients, particularly the greater use of NIV as first-line ventilation strategy. Compared with immunocompetent subjects, they have higher mortality regardless of ARDS severity as well as a higher frequency of limitation of life-sustaining measures. Nonetheless, nearly half of these patients survive to hospital discharge.

Trial Registration: ClinicalTrials.gov, NCT02010073 . Registered on 12 December 2013.

Citing Articles

Identification and experimental validation of diagnostic and prognostic genes CX3CR1, PID1 and PTGDS in sepsis and ARDS using bulk and single-cell transcriptomic analysis and machine learning.

Jiang J, Chen Y, Su Y, Zhang L, Qian H, Song X Front Immunol. 2025; 15:1480542.

PMID: 39763654 PMC: 11700820. DOI: 10.3389/fimmu.2024.1480542.

Lung immune incompetency after mild peritoneal sepsis and its partial restoration by type 1 interferon: a mouse model study.

Meng Q, Seto F, Totsu T, Miyashita T, Wu S, Bougaki M Intensive Care Med Exp. 2024; 12(1):119.

PMID: 39707074 PMC: 11662124. DOI: 10.1186/s40635-024-00707-7.

Developing a digital phenotype to subdivide adult immunosuppressed COVID-19 outcomes within the English Primary Care Sentinel Network.

Leston M, Kar D, Forbes A, Jamie G, Wimalaratna R, Jiwani G Front Immunol. 2024; 15:1491565.

PMID: 39697345 PMC: 11652345. DOI: 10.3389/fimmu.2024.1491565.

Management of analgosedation during noninvasive respiratory support: an expert Delphi consensus document developed by the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI).

Spinazzola G, Spadaro S, Ferrone G, Grasso S, Maggiore S, Cinnella G J Anesth Analg Crit Care. 2024; 4(1):68.

PMID: 39350290 PMC: 11441104. DOI: 10.1186/s44158-024-00203-0.

Early identification and diagnosis, pathophysiology, and treatment of sepsis-related acute lung injury: a narrative review.

Zhang J, Yan W, Dong Y, Luo X, Miao H, Maimaijuma T J Thorac Dis. 2024; 16(8):5457-5476.

PMID: 39268131 PMC: 11388254. DOI: 10.21037/jtd-24-1191.

References

Kostakou E, Rovina N, Kyriakopoulou M, Koulouris N, Koutsoukou A . Critically ill cancer patient in intensive care unit: issues that arise. J Crit Care. 2014; 29(5):817-22. DOI: 10.1016/j.jcrc.2014.04.007. View

Azoulay E, Soares M, Benoit D . Focus on immunocompromised patients. Intensive Care Med. 2016; 42(3):463-465. DOI: 10.1007/s00134-016-4224-8. View

Contejean A, Lemiale V, Resche-Rigon M, Mokart D, Pene F, Kouatchet A . Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study. Ann Intensive Care. 2016; 6(1):102. PMC: 5080277. DOI: 10.1186/s13613-016-0202-0. View

Normilio-Silva K, de Figueiredo A, Pedroso-de-Lima A, Tunes-da-Silva G, Nunes da Silva A, Delgado Dias Levites A . Long-Term Survival, Quality of Life, and Quality-Adjusted Survival in Critically Ill Patients With Cancer. Crit Care Med. 2016; 44(7):1327-37. DOI: 10.1097/CCM.0000000000001648. View

Azevedo L, Caruso P, Silva U, Torelly A, Silva E, Rezende E . Outcomes for patients with cancer admitted to the ICU requiring ventilatory support: results from a prospective multicenter study. Chest. 2014; 146(2):257-266. DOI: 10.1378/chest.13-1870. View

Bellani G, Laffey J, Pham T, Madotto F, Fan E, Brochard L . Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE Study. Am J Respir Crit Care Med. 2016; 195(1):67-77. DOI: 10.1164/rccm.201606-1306OC. View

Thille A, Contou D, Fragnoli C, Cordoba-Izquierdo A, Boissier F, Brun-Buisson C . Non-invasive ventilation for acute hypoxemic respiratory failure: intubation rate and risk factors. Crit Care. 2013; 17(6):R269. PMC: 4057073. DOI: 10.1186/cc13103. View

Laffey J, Bellani G, Pham T, Fan E, Madotto F, Bajwa E . Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study. Intensive Care Med. 2016; 42(12):1865-1876. DOI: 10.1007/s00134-016-4571-5. View

Antonelli M, Conti G, Bufi M, Costa M, Lappa A, Rocco M . Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial. JAMA. 2000; 283(2):235-41. DOI: 10.1001/jama.283.2.235. View

10.

Ranieri V, Rubenfeld G, Thompson B, Ferguson N, Caldwell E, Fan E . Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 307(23):2526-33. DOI: 10.1001/jama.2012.5669. View

11.

Depuydt P, Benoit D, Vandewoude K, Decruyenaere J, Colardyn F . Outcome in noninvasively and invasively ventilated hematologic patients with acute respiratory failure. Chest. 2004; 126(4):1299-306. DOI: 10.1378/chest.126.4.1299. View

12.

Lemiale V, Mokart D, Resche-Rigon M, Pene F, Mayaux J, Faucher E . Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial. JAMA. 2015; 314(16):1711-9. DOI: 10.1001/jama.2015.12402. View

13.

Demoule A, Chevret S, Carlucci A, Kouatchet A, Jaber S, Meziani F . Changing use of noninvasive ventilation in critically ill patients: trends over 15 years in francophone countries. Intensive Care Med. 2015; 42(1):82-92. DOI: 10.1007/s00134-015-4087-4. View

14.

Molina R, Bernal T, Borges M, Zaragoza R, Bonastre J, Granada R . Ventilatory support in critically ill hematology patients with respiratory failure. Crit Care. 2012; 16(4):R133. PMC: 3580718. DOI: 10.1186/cc11438. View

15.

Frat J, Ragot S, Girault C, Perbet S, Prat G, Boulain T . Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial. Lancet Respir Med. 2016; 4(8):646-652. DOI: 10.1016/S2213-2600(16)30093-5. View

16.

Gregoretti C, Pisani L, Cortegiani A, Ranieri V . Noninvasive ventilation in critically ill patients. Crit Care Clin. 2015; 31(3):435-57. DOI: 10.1016/j.ccc.2015.03.002. View

17.

Azoulay E, Lemiale V, Mokart D, Pene F, Kouatchet A, Perez P . Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med. 2014; 40(8):1106-14. DOI: 10.1007/s00134-014-3354-0. View

18.

Mokart D, Pastores S, Darmon M . Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med. 2014; 40(10):1570-2. DOI: 10.1007/s00134-014-3433-2. View

19.

Bellani G, Laffey J, Pham T, Fan E, Brochard L, Esteban A . Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016; 315(8):788-800. DOI: 10.1001/jama.2016.0291. View

20.

Huang H, Xu B, Liu G, Lin J, Du B . Use of noninvasive ventilation in immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis. Crit Care. 2017; 21(1):4. PMC: 5219799. DOI: 10.1186/s13054-016-1586-9. View